Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Patrono

Showing results (21-30 of 257) with videos related to

Pageof 26
Sort By:
European Heart Journal|December 16, 2023
Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT fewGiovanna Liuzzo, Carlo Patrono
European Heart Journal|August 6, 2021
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetesMassimo Volpe, Carlo Patrono
European Heart Journal|November 18, 2021
Does abbreviated dual antiplatelet therapy after PCI provide a clinically meaningful trade-off between bleeding and ischaemic events in patients at high risk for bleeding?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|December 21, 2021
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?Massimo Volpe, Carlo Patrono
European Heart Journal|January 1, 2022
A fixed-dose combination treatment strategy to reduce premature cardiovascular disease deaths globallyGiovanna Liuzzo, Carlo Patrono
European Heart Journal|March 4, 2021
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19Massimo Volpe, Carlo Patrono
European Heart Journal|February 21, 2022
In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failureGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 10, 2022
Age-independent benefits of blood pressure lowering: are they applicable to all patients?Massimo Volpe, Carlo Patrono
Lancet (London, England)|October 17, 2008
Selective COX-2 inhibitors: where do we go from here?Colin Baigent, Carlo Patrono
Journal of the American College of Cardiology|August 27, 2016
Aspirin and CancerPaola Patrignani, Carlo Patrono
Pageof 26

Showing results (21-30 of 257) with videos related to

Sort By:
Pageof 26
European Heart Journal|December 16, 2023
Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT fewGiovanna Liuzzo, Carlo Patrono
European Heart Journal|August 6, 2021
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetesMassimo Volpe, Carlo Patrono
European Heart Journal|November 18, 2021
Does abbreviated dual antiplatelet therapy after PCI provide a clinically meaningful trade-off between bleeding and ischaemic events in patients at high risk for bleeding?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|December 21, 2021
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?Massimo Volpe, Carlo Patrono
European Heart Journal|January 1, 2022
A fixed-dose combination treatment strategy to reduce premature cardiovascular disease deaths globallyGiovanna Liuzzo, Carlo Patrono
European Heart Journal|March 4, 2021
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19Massimo Volpe, Carlo Patrono
European Heart Journal|February 21, 2022
In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failureGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 10, 2022
Age-independent benefits of blood pressure lowering: are they applicable to all patients?Massimo Volpe, Carlo Patrono
Lancet (London, England)|October 17, 2008
Selective COX-2 inhibitors: where do we go from here?Colin Baigent, Carlo Patrono
Journal of the American College of Cardiology|August 27, 2016
Aspirin and CancerPaola Patrignani, Carlo Patrono
Pageof 26